<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
85816-2164-2
</NDCCode>
<PackageDescription>
500 mL in 1 JAR (85816-2164-2)
</PackageDescription>
<NDC11Code>
85816-2164-02
</NDC11Code>
<ProductNDC>
85816-2164
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Bm Bm164 Drops
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Arum Tryph, Causticum, Balsamum Peru, Helonias Dio, Acid Phos, Glycerinum, Equisetum
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20150101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED HOMEOPATHIC
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
BM Private Limited
</LabelerName>
<SubstanceName>
ARISAEMA TRIPHYLLUM ROOT; CAUSTICUM; BALSAM PERU; CHAMAELIRIUM LUTEUM ROOT; PHOSPHORIC ACID; GLYCERIN; EQUISETUM HYEMALE WHOLE
</SubstanceName>
<StrengthNumber>
100; 100; 100; 70; 100; 100; 100
</StrengthNumber>
<StrengthUnit>
[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
</StrengthUnit>
<Pharm_Classes>
Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-08-17
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20150101
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>